Prostate cancer Board decisions

The Veteran's prostate cancer in remission, erectile dysfunction, and pelvic surgical scar are all being reviewed for potential increased ratings. The VA will obtain updated treatment records and schedule the Veteran for a VA examination to assess his current conditions.

The Board has remanded the case due to inadequate medical opinions and missing VA treatment records. The Veteran's claim for service connection for post-operative residuals of prostate cancer will be further evaluated after obtaining additional evidence.

The Veteran's cause of death is being remanded due to the need for additional information regarding his service and exposure to herbicides. The appellant seeks service connection for the cause of death based on presumed Agent Orange exposure.

The Veteran's prostate cancer was not present during service or for many years thereafter. The Veteran served at Camp Leune, but there is no evidence of actual exposure to contaminated water that could support a claim based on herbicide exposure. Therefore, the claim for service connection for prostate cancer is denied.

The Veteran's service-connected residuals of prostate cancer are rated at 40% prior to November 8, 2014 and at 60% thereafter. The Veteran's service-connected hepatitis B is currently not symptomatic and thus does not meet the criteria for a compensable rating.

The Veteran's prostate cancer and its resulting complications, including erectile dysfunction, were not the result of VA treatment, including testosterone replacement therapy.,The Veteran's erectile dysfunction is not caused or aggravated by a service-connected disability.

The Veteran seeks service connection for prostate cancer, which he contends is related to ionizing radiation exposure during his military service. The case has been remanded due to the need for a dose assessment of exposure and an advisory opinion on whether the Veteran's radiogenic disease (prostate cancer) is related to his in-service radiation exposure.

The Veteran's increased disability rating claim for prostate cancer residuals from August 1, 2010 was denied as the reduction in evaluation to 60% was proper by operation of law under DC 7528. The Board found that there was no evidence of active malignancy or recurrence after August 1, 2010.

The Board has determined that the reduction of the evaluation for prostate cancer from 100 percent to 60 percent, effective September 1, 2009, was proper as the Veteran's prostate cancer is in remission.

The Veteran's claim for service connection for a respiratory/pulmonary disorder, including tuberculosis and asbestosis, was denied due to lack of evidence. New evidence did not raise a reasonable possibility of substantiating the claim.,The Veteran's claim for service connection for prostate cancer was previously denied based on lack of exposure to Agent Orange. New evidence suggests possible exposure during service in Vietnam.

The Veteran's service-connected disabilities do not preclude him from securing or following a substantially gainful occupation consistent with his education and occupational experience.

The Veteran's prostate cancer was reduced from a 100% to a 40% rating effective May 1, 2010. The Board found that the reduction was proper and granted an initial PTSD rating of 50%. No TDIU was granted.

The Veteran's claims for prostate cancer and skin cancer are being remanded due to the need for additional development, including obtaining dose data from the Department of Defense regarding his exposure during Operation Redwing. His hearing loss claim is also being remanded for an updated VA examination.

The Veteran died in January 2013 due to pancreatic cancer, which was not related to service or presumed herbicide exposure. His prostate cancer and diabetes did not cause his death.

The Veteran's prostate cancer is found to be related to his military service, with the Board finding that exposure to dioxins in Guam contributed to his risk for prostate cancer.

The Board has denied the Veteran's claim for service connection for hypertension. The prostate cancer claim is pending and will be remanded for further development.

The Board has remanded the case for additional development to determine if the Veteran was exposed to herbicide exposure while serving on the USS Shasta and whether this exposure is related to his prostate cancer.

The Veteran's residuals of prostate cancer have been rated at 60 percent since May 4, 2010. The issue of service connection for thrombophlebitis, right lower leg is currently pending and will be addressed in a separate decision.

The Veteran's claims for service connection for a dental disorder, diabetes mellitus, prostate cancer, and glaucoma (secondary to diabetes) have been denied. The Board found that the evidence did not meet the criteria for direct service connection in all cases.

The Veteran is seeking an initial compensable evaluation for his erectile dysfunction. The Board observes that the Veteran's service-connected erectile dysfunction is already compensated for an inability to perform sexual intercourse with a special monthly compensation based on the loss of use of a creative organ. However, he asserts total impotence and deformity of the penis following September 2008 surgery for prostate cancer.